Serkan Ozakbas
Medical Point Hospital
Izmir, Turkey
Izmir, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 177 publications
Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 03, 2026
Causal effects of multiple sclerosis therapies in left-truncated registry data.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 21, 2026
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 28, 2026
Corrigendum to "Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis: An MSBase registry sub-study" [Multiple Sclerosis and Related Disorders Vol 106; Feb 2026; Article Number 106885].
Journal: Multiple sclerosis and related disorders
Published: April 10, 2026
Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.
Journal: Brain : a journal of neurology
Published: March 12, 2026
Managing reactivation of multiple sclerosis during treatment with natalizumab.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: December 20, 2025
Impact of pain subtypes on disability and quality of life in multiple sclerosis: Neuropathic pain demonstrates the strongest association.
Journal: Multiple sclerosis and related disorders
Published: December 07, 2025
Real-world transition from uncontrolled disease to stability: Three-year Pre-post natalizumab comparison in relapsing multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: November 21, 2025
Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.
Journal: Therapeutic advances in neurological disorders
Published: November 09, 2025
Integrating Reproductive and Clinical Variables to Predict Postpartum Disability Outcomes in Multiple Sclerosis Using Machine Learning.
Journal: Multiple sclerosis and related disorders
Published: November 08, 2025
Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.
Journal: Journal of neurology
Published: November 01, 2025
No evidence of disease activity after fingolimod treatment: A three-year real-world comparison of pre- and post-treatment outcomes in multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: October 28, 2025
Last Updated: 09/26/2026